The drug resistance surveillance of bauman acinetobacter baumannii resisted to imipenem
10.3760/cma.j.issn.1008-6315.2014.05.008
- VernacularTitle:对亚胺培南耐药鲍曼不动杆菌的耐药性监测
- Author:
Jianping ZHAO
;
Xiulan ZHOU
- Publication Type:Journal Article
- Keywords:
Imipenem;
Acinetobacter baumannii;
Intensive care unit;
Multiple drug resistance
- From:
Clinical Medicine of China
2014;30(5):472-474
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the distribution of the Bauman acinetobacter baumannii (IRAB) resisted to imipenem and character of drug resistance.Methods Retrospective analyzed 517 strains of IRAB and 319 strains of imipenem drug resistance of acinetobacter baumannii from South Africa (not IRAB) by VITEK 2 compact automatic bacterial culture identification.Results IRAB positive rate was 61.8％ (517/836).The main source of IRAB was from sputum(85.5％ (442/517)).The constitute ratio of main areas in IRAB was ICU ward (55.9％) and only 7.8％ in non-IRAB.The resistant rate of IRAB to amikacin was 27.2％.The resistant rate of non-IRAB to Amikacin and piperacillin/tazobactam were 8.0％ (21/262),8.2％ (26/317),suggesting the good antibacterial activity.In terms of rate of resistance drug,apart from Cefazolin,Cefotetan,Cotrimoxazole,Nitrofurantoin,the sort of antibacterial drugs against IRAB was obviously higher than that of non-IRAB,and difference was statistically significant (P ＜ 0.05).Conclusion Drug resistance surveillance should be strengthened because of high detection rate and drug resistance in ICU in terms of IRAB.Combination therapy and related intervention measures might effective control of infection and IRAB.
